Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
about
Hepatitis C genotype 6: A concise review and response-guided therapy proposalHepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical PracticeHepatitis C virus: Virology, diagnosis and treatmentHCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasmaHigh-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methodsHCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes.A novel hepatitis C virus genotyping method based on liquid microarrayHepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance ratePerformance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotypingEvaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patientsEvaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping.Distribution of Hepatitis C Virus Genotypes in Bahrain.High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatmentHepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated regionSequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6.Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.Systematic review: epidemiology of hepatitis C genotype 6 and its management.Systematic review: Asian patients with chronic hepatitis C infection.Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.Diagnosis and Management of Hepatitis C Virus Infection.APASL consensus statements and management algorithms for hepatitis C virus infection.Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping.Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs.SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells.Hepatitis C Virus Genotype and Subtype Distribution in Patient Specimens Tested at the University of Texas Medical Branch, Galveston, Between January 2011 and November 2014.Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study.Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches.Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.
P2860
Q22305417-926FF070-F8EA-4AAF-8847-A141CBBCF433Q27490447-7083C807-FCE2-42B5-98DE-7C2BB4A0AA45Q28082000-24D563EF-3D8A-4C3B-9EF4-A08982897196Q28545256-0E19E2D1-E117-4A95-8B7A-B2B155186697Q28652352-03F3323D-E7D6-4610-8CD0-B2DE4698398AQ33645428-DA886BED-C8C8-4393-A510-3C64442234EBQ33700325-4950DB37-C124-428F-B0C6-615C0A5C69AEQ34008754-0CF7CBC2-06F9-4D3B-BC94-009859722D04Q34130628-94470AAD-BE8D-489B-A373-FBB978B7A7F8Q34298265-770D7B5D-CD1C-47A5-A26E-F4108024DF3EQ35455627-5E06CCBD-36A0-4573-A495-47131A63CAD2Q35990080-9EF28D1E-C925-47C7-8ED4-1E4C3568E23BQ36270128-55F7FDB7-6D28-4D15-9997-CA12CFF5965BQ36639886-5EB5D0E4-6355-42CE-BDB7-3AC6365C4A9FQ36676315-32124B4C-9EEB-4A16-828D-068C89B84C85Q36702487-74FA46B0-2A2D-4810-81B8-6466B053DFE9Q36826804-96A80C13-61EC-4A4A-B0EE-6F96743CB5FBQ37040485-096274E0-E184-40D7-8424-AFDC9CCCD533Q37125237-8A2FDE81-929C-41C3-981B-F51E9E160074Q37286221-1C95C3A0-2CD2-4FF4-9A21-3EFAD5216B7FQ37682493-76D1700F-565A-43CB-9A40-811EBABAFCBBQ37882006-AA9B49EE-587A-4BA8-A526-E00D58BC64A1Q38096012-B90D8D25-A705-49EC-9F7D-4C904F959620Q38164114-425CDBBB-89E9-400C-B1C6-B8C427325B34Q38327430-309271FB-9E17-4C07-A4E5-2D7177ECE50BQ38552131-EBFCC29B-5BE6-4043-863A-A39B32A6D2D0Q38866070-9BA0CC15-A2D7-42A8-B92E-9D0CD4E706DEQ38992041-006FE43F-C3BF-4063-8A91-74A98A1658F6Q39533745-FDB7031B-FD15-4862-AEE5-734A7279FF53Q39641275-60115358-F145-4082-8014-607AB957D33AQ39791492-5DAF03DC-C94D-4934-BE84-B8F09E6BD4D1Q39904754-2278E869-680E-45C2-BF00-07D65663F12DQ40419604-F0DE6639-6075-4A40-B418-0688BB5BAA1DQ40518926-9ACAF1A1-97E5-44F7-8607-18D953539CB9Q40857029-7E1DE9E9-FA7C-49C5-91BE-2A5305AB63C3Q41829739-9D02A34B-91B4-4080-A16F-E00D107B51CEQ42205040-97F3B966-151B-411F-B2A7-15AAFD4889B1Q42270437-DC90D735-AD13-4858-BD85-6ABB1E21AE7AQ42716855-7B8119F9-4C6E-4CAF-BCAE-8343C5A16110Q42994500-BD131B9B-09DC-410A-A8AD-79ED5AE34188
P2860
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@ast
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@en
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@nl
type
label
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@ast
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@en
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@nl
prefLabel
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@ast
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@en
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@nl
P2093
P2860
P50
P3181
P356
P1476
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
@en
P2093
Alice Farrior
Carl Schaper
Judy Morimoto
Linda Celis
Margaret Jankowski-Hennig
Marianne Van Brussel
Mark J Stanley
Pamela Johnson
P2860
P304
P3181
P356
10.1128/JCM.02390-07
P407
P577
2008-06-01T00:00:00Z